Calliditas Therapeutics Says Liver Disease Therapy Met Main Goal in Phase 2b Study
Calliditas Therapeutics Says Liver Disease Therapy Met Main Goal in Phase 2b Study
calliditas therapeutics表示,肝脏疾病治疗在第20亿阶段研究中达到了主要目标。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册